Search

According to the global cancer statistics in 2022 updated by the International Agency for Research on Cancer (IARC), there were nearly 20 million new cases of cancer and 9.7 million deaths. Lung cancer was the most commonly diagnosed cancer, accounting for nearly 2.5 million new cases (12.4% of all global cancers), followed by female breast cancer (11.6%), colorectal cancer (9.6%), prostate cancer (7.3%), and stomach cancer (4.9%). Lung cancer was also the leading cause of cancer deaths, with an estimated 1.8 million deaths (18.7%), followed by colorectal cancer (9.3%), liver cancer (7.8%), female breast cancer (6.9%), and stomach cancer (6.8%). Population-based projections suggest that the number of new cancer cases will reach 35 million by 2050. Increasing the investment in prevention and control measures targeting key cancer risk factors, including smoking, obesity, and infections, could save many lives globally and bring significant economic and social returns to countries in the coming decades.

Autophagy is an important catabolic process to maintain cellular homeostasis and antagonize cellular stresses. The initiation and activation are two of the most important aspects of the autophagic process. This review focuses on mechanisms underlying autophagy initiation and activation and signaling pathways regulating the activation of autophagy found in recent years. These findings include autophagy initiation by liquid–liquid phase separation (LLPS), autophagy initiation in the endoplasmic reticulum (ER) and Golgi apparatus, and the signaling pathways mediated by the ULK1 complex, the mTOR complex, the AMPK complex, and the PI3KC3 complex. Through the review, we attempt to present current research progress in autophagy regulation and forward our understanding of the regulatory mechanisms and signaling pathways of autophagy initiation and activation. [ABSTRACT FROM AUTHOR]

With the continuous evolution of international trade, the global market has been steadily expanding while also facing increasing challenges, particularly in relation to the introduction of environmental policies such as carbon barriers. Our research explores how China's power battery manufacturers can adapt their export strategies to the EU's carbon barrier policies. Additionally, we examine the roles of government regulations, research institutions, and manufacturers in either facilitating or hindering compliance with carbon reduction objectives. Using evolutionary game theory, we construct models involving government entities, manufacturers, and research institutions to systematically analyze market evolution, strategic interactions, and outcomes among these stakeholders. Our analysis focuses on understanding the competitive dynamics faced by exporting countries under stringent environmental policies and provides strategic insights to guide export strategies. Taking the EU's carbon barrier policy as a case study, we explore Chinese battery manufacturers' adaptive strategies and decision-making processes as they respond to shifting market demands and regulatory environments. The findings not only offer valuable insights into exporting countries but also provide policymakers with information on international trade and industrial policy design. Furthermore, we validate our model through numerical simulations and conduct sensitivity analyses on key parameters. The results underscore the importance of governmental adoption of punitive and incentive policies, revealing their substantial impact on stakeholder behavior. Additionally, the study highlights how participants' pre-cooperation losses and post-cooperation gains influence participation rates and the speed at which stakeholder consensus is reached. By offering a novel approach with which to address carbon barrier challenges, this research contributes valuable perspectives on environmental regulations' strategic and policy implications in global trade. [ABSTRACT FROM AUTHOR]

This research investigates the volatility of carbon prices in Guangdong's emission trading market, a critical element of China's broader climate strategy aimed at reducing greenhouse gas emissions and promoting sustainable development. This study applies ensemble empirical mode decomposition (EEMD) to analyze the complex interactions between carbon price fluctuations and various economic factors, including energy prices and environmental regulations. By decomposing the data, we identify key trends and cycles within the market, providing a clearer understanding of both short-term volatility and long-term market trends. Our findings reveal that regulatory policies play a pivotal role in shaping carbon market dynamics, with shifts in regulations leading to significant price volatility. Additionally, fluctuations in global energy prices, especially oil and coal, are found to have a considerable impact on carbon price movements, further complicating the market's stability. This underscores the interconnected nature of the carbon trading market with broader economic and environmental factors, both domestic and international. The findings provide valuable insights for policymakers and market participants, underscoring the importance of stable carbon markets for promoting the transition to a low-carbon economy and achieving broader sustainability goals. [ABSTRACT FROM AUTHOR]

Long-acting injectable (LAI) formulations of antiretrovirals (ARVs) as pre-exposure prophylaxis (PrEP) could be an attractive alternative for men who have sex with men (MSM) who are interested in ARV-based biomedical prevention but will not use a daily pill. This study investigated interest in LAI-PrEP in a cohort of MSM in China and characterized how MSM willing to use only injectable PrEP differed from MSM who would use PrEP regardless of modality or not at all. Demographic, behavioral, and risk perception measures were collected and associations investigated. A licensed LAI-PrEP agent would increase the proportion interested in PrEP by 24.5% over oral PrEP alone. Combining interest in oral and injectable PrEP, 78.5% of the sample could be covered if reported interest in PrEP translated into actual uptake. Partnership factors differentiated those who would be willing to use only LAI-PrEP versus any PrEP modality, while higher self-perception of risk was associated with interest in LAI-PrEP versus no PrEP. The addition of a second PrEP modality could yield increased population coverage of PrEP. Social and behavioral research should be undertaken in parallel with clinical development of injectable PrEP agents to identify characteristics of those who are not interested in oral PrEP but would take advantage of ARV-based prevention with the introduction of an injectable product.

Hermansky–Pudlak syndrome (HPS)-associated pulmonary fibrosis (HPS-PF) is a progressive lung disease that is a major cause of morbidity and mortality in HPS patients. Previous studies have demonstrated that the HPS proteins play an essential role in the biogenesis and function of lysosome-related organelles (LROs) in alveolar epithelial type II (AT2) cells and found that HPS-PF is associated with dysfunction of AT2 cells and abnormal immune reactions. Despite recent advances in research on HPS and the pathology of HPS-PF, the pathological mechanisms underlying HPS-PF remain poorly understood, and no effective treatment has been established. Therefore, it is necessary to refresh the progress in the pathogenesis of HPS-PF to increase our understanding of the pathogenic mechanism of HPS-PF and develop targeted therapeutic strategies. This review summarizes the recent progress in the pathogenesis of HPS-PF provides information about the current treatment strategies for HPS-PF, and hopefully increases our understanding of the pathogenesis of HPS-PF and offers thoughts for new therapeutic interventions. [ABSTRACT FROM AUTHOR]

Using peanut shells, a sustainable agricultural waste product, as its raw material, the acid group-modified biochar (AMBC) was prepared through phosphoric acid activation, partial carbonization, and concentrated sulfuric acid sulfonation for efficient removal of lead ion from aqueous solutions. Characterization techniques such as N2 isothermal adsorption–desorption, SEM, XRD, FT-IR, TG-DTA, and acid–base titration were utilized to fully understand the properties of the AMBC. It was found that there were high densities of acidic oxygen-containing functional groups (-SO3H, -COOH, Ph-OH) on the surface of the AMBC. The optimal adsorption performance of the AMBC for Pb(II) in water occurred when the initial concentration of Pb(II) was 100 mg/L, the pH was 5, the dosage of the adsorbent was 0.5 g/L, and the contact time was 120 min. Under the optimal conditions, the removal ratio of Pb(II) was 76.0%, with an adsorption capacity of 148.6 mg/g. This performance far surpassed that of its activated carbon precursor, which achieved a removal ratio of 39.7% and an adsorption capacity of 83.1 mg/g. The superior adsorption performance of AMBC can be caused by the high content of acidic oxygen-containing functional groups on its surface. These functional groups facilitate the strong binding between AMBC and Pb(II), enabling effective removal from water solutions. [ABSTRACT FROM AUTHOR]

Lycopene is a promising biological functional component with various biological activities and excellent pharmacological activities. However, its low water solubility and stability lead to low oral bioavailability, which limits its edible and medicinal research. Then, it is necessary to explore effective methods to protect lycopene from destruction and further exploit its potential benefits. The absorption of lycopene in vivo is affected by solubility, stability, isomer type, emulsifying ability, difficulty in forming micelles in vivo, and interaction with food components. Emulsions, pickering emulsions, micelles, liposomes, bigels, beasds, solid dispersions, microcapsules, nanoparticles, electrospinning and other drug delivery systems can be used as good strategies to improve the stability and bioavailability of lycopene. In this paper, the absorption process of lycopene in vivo and the factors affecting its bioavailability were discussed, and the preparation strategies for improving the stability, bioavailability, and health benefits of lycopene were reviewed, to provide some clues and references for the full utilization of lycopene in the field of health. However, there are still various unresolved mysteries regarding the metabolism of lycopene. The safety and in vivo studies of various preparations should be further explored, and the above technologies also face the challenge of industrial production. [ABSTRACT FROM AUTHOR]